I get it and completely agree with it...if what I think and hope will happen in the next 3 months! If it doesn't happen then I may question it, but all signs and PRs are pointing to a much much much higher valuation in the next couple of months. IMO.
"We believe we are on track with Brilacidin to become the first in a new class of antibiotics to be approved in over 20 years."